EMILY SMITH: Open Payments
NPI 1720751159 · CHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,715 in 92 payments from 18 companies in 2025. Trend: 2023 $1,316 · 2024 $1,607 · 2025 $1,715
Food & beverage: $1,715
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $390 |
| PFIZER INC. | 18 | $323 |
| ABBVIE INC. | 15 | $205 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $185 |
| Lilly USA, LLC | 10 | $166 |
| AstraZeneca Pharmaceuticals LP | 5 | $91 |
| SHIELD THERAPEUTICS INC | 1 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Exact Sciences Corporation | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $35 |
Products named: Wegovy, CAPLYTA, ELIQUIS, MOUNJARO, Ozempic, NURTEC ODT, QULIPTA, VRAYLAR.
Industry payments across VA — which companies pay providers there.
